The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Poultry Live Attenuated Vaccine Market Research Report 2025
Synopsis
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird's immune system to develop a protective response without causing severe illness.
The global Poultry Live Attenuated Vaccine market was valued at US$ 2135 million in 2023 and is anticipated to reach US$ 2633.8 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
North American market for Poultry Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Poultry Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Poultry Live Attenuated Vaccine include MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Poultry Live Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poultry Live Attenuated Vaccine.
Report Scope
The Poultry Live Attenuated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poultry Live Attenuated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poultry Live Attenuated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MERCK
Boehringer Ingelheim
CEVA
ZOETIS
Vaxxinova
ELANCO
QYH BIOTECH
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
HARBIN PHARMACEUTICAL GROUP
MEVAC
VENKY’S
Dechra
Segment by Type
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Other
Segment by Application
Chicken
Other Poultry
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poultry Live Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poultry Live Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Poultry live attenuated vaccines are a type of vaccine used in the poultry industry to protect birds from various infectious diseases. Live attenuated vaccines contain weakened or modified forms of the pathogen that causes the disease, allowing the bird's immune system to develop a protective response without causing severe illness.
The global Poultry Live Attenuated Vaccine market was valued at US$ 2135 million in 2023 and is anticipated to reach US$ 2633.8 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
North American market for Poultry Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Poultry Live Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Poultry Live Attenuated Vaccine include MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Poultry Live Attenuated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poultry Live Attenuated Vaccine.
Report Scope
The Poultry Live Attenuated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Poultry Live Attenuated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poultry Live Attenuated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MERCK
Boehringer Ingelheim
CEVA
ZOETIS
Vaxxinova
ELANCO
QYH BIOTECH
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
HARBIN PHARMACEUTICAL GROUP
MEVAC
VENKY’S
Dechra
Segment by Type
NDV
Marek ' s Disease
IBD
Infectious Bronchitis
Influenza
Other
Segment by Application
Chicken
Other Poultry
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poultry Live Attenuated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poultry Live Attenuated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Poultry Live Attenuated Vaccine Market Overview
1.1 Product Overview and Scope of Poultry Live Attenuated Vaccine
1.2 Poultry Live Attenuated Vaccine Segment by Type
1.2.1 Global Poultry Live Attenuated Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 NDV
1.2.3 Marek ' s Disease
1.2.4 IBD
1.2.5 Infectious Bronchitis
1.2.6 Influenza
1.2.7 Other
1.3 Poultry Live Attenuated Vaccine Segment by Application
1.3.1 Global Poultry Live Attenuated Vaccine Market Value by Application: (2024-2030)
1.3.2 Chicken
1.3.3 Other Poultry
1.4 Global Poultry Live Attenuated Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poultry Live Attenuated Vaccine Revenue 2019-2030
1.4.2 Global Poultry Live Attenuated Vaccine Sales 2019-2030
1.4.3 Global Poultry Live Attenuated Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Poultry Live Attenuated Vaccine Market Competition by Manufacturers
2.1 Global Poultry Live Attenuated Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Poultry Live Attenuated Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Poultry Live Attenuated Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Poultry Live Attenuated Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Poultry Live Attenuated Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Poultry Live Attenuated Vaccine, Product Type & Application
2.7 Poultry Live Attenuated Vaccine Market Competitive Situation and Trends
2.7.1 Poultry Live Attenuated Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Poultry Live Attenuated Vaccine Players Market Share by Revenue
2.7.3 Global Poultry Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Poultry Live Attenuated Vaccine Retrospective Market Scenario by Region
3.1 Global Poultry Live Attenuated Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Poultry Live Attenuated Vaccine Global Poultry Live Attenuated Vaccine Sales by Region: 2019-2030
3.2.1 Global Poultry Live Attenuated Vaccine Sales by Region: 2019-2024
3.2.2 Global Poultry Live Attenuated Vaccine Sales by Region: 2025-2030
3.3 Global Poultry Live Attenuated Vaccine Global Poultry Live Attenuated Vaccine Revenue by Region: 2019-2030
3.3.1 Global Poultry Live Attenuated Vaccine Revenue by Region: 2019-2024
3.3.2 Global Poultry Live Attenuated Vaccine Revenue by Region: 2025-2030
3.4 North America Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.4.1 North America Poultry Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Poultry Live Attenuated Vaccine Sales by Country (2019-2030)
3.4.3 North America Poultry Live Attenuated Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.5.1 Europe Poultry Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Poultry Live Attenuated Vaccine Sales by Country (2019-2030)
3.5.3 Europe Poultry Live Attenuated Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Poultry Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Poultry Live Attenuated Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Poultry Live Attenuated Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.7.1 Latin America Poultry Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Poultry Live Attenuated Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Poultry Live Attenuated Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Poultry Live Attenuated Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Poultry Live Attenuated Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Poultry Live Attenuated Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Poultry Live Attenuated Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Poultry Live Attenuated Vaccine Sales by Type (2019-2030)
4.1.1 Global Poultry Live Attenuated Vaccine Sales by Type (2019-2024)
4.1.2 Global Poultry Live Attenuated Vaccine Sales by Type (2025-2030)
4.1.3 Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Poultry Live Attenuated Vaccine Revenue by Type (2019-2030)
4.2.1 Global Poultry Live Attenuated Vaccine Revenue by Type (2019-2024)
4.2.2 Global Poultry Live Attenuated Vaccine Revenue by Type (2025-2030)
4.2.3 Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Poultry Live Attenuated Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Poultry Live Attenuated Vaccine Sales by Application (2019-2030)
5.1.1 Global Poultry Live Attenuated Vaccine Sales by Application (2019-2024)
5.1.2 Global Poultry Live Attenuated Vaccine Sales by Application (2025-2030)
5.1.3 Global Poultry Live Attenuated Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Poultry Live Attenuated Vaccine Revenue by Application (2019-2030)
5.2.1 Global Poultry Live Attenuated Vaccine Revenue by Application (2019-2024)
5.2.2 Global Poultry Live Attenuated Vaccine Revenue by Application (2025-2030)
5.2.3 Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Poultry Live Attenuated Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MERCK
6.1.1 MERCK Corporation Information
6.1.2 MERCK Description and Business Overview
6.1.3 MERCK Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MERCK Poultry Live Attenuated Vaccine Product Portfolio
6.1.5 MERCK Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Poultry Live Attenuated Vaccine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 CEVA
6.3.1 CEVA Corporation Information
6.3.2 CEVA Description and Business Overview
6.3.3 CEVA Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CEVA Poultry Live Attenuated Vaccine Product Portfolio
6.3.5 CEVA Recent Developments/Updates
6.4 ZOETIS
6.4.1 ZOETIS Corporation Information
6.4.2 ZOETIS Description and Business Overview
6.4.3 ZOETIS Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ZOETIS Poultry Live Attenuated Vaccine Product Portfolio
6.4.5 ZOETIS Recent Developments/Updates
6.5 Vaxxinova
6.5.1 Vaxxinova Corporation Information
6.5.2 Vaxxinova Description and Business Overview
6.5.3 Vaxxinova Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vaxxinova Poultry Live Attenuated Vaccine Product Portfolio
6.5.5 Vaxxinova Recent Developments/Updates
6.6 ELANCO
6.6.1 ELANCO Corporation Information
6.6.2 ELANCO Description and Business Overview
6.6.3 ELANCO Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ELANCO Poultry Live Attenuated Vaccine Product Portfolio
6.6.5 ELANCO Recent Developments/Updates
6.7 QYH BIOTECH
6.6.1 QYH BIOTECH Corporation Information
6.6.2 QYH BIOTECH Description and Business Overview
6.6.3 QYH BIOTECH Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QYH BIOTECH Poultry Live Attenuated Vaccine Product Portfolio
6.7.5 QYH BIOTECH Recent Developments/Updates
6.8 PULIKE
6.8.1 PULIKE Corporation Information
6.8.2 PULIKE Description and Business Overview
6.8.3 PULIKE Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PULIKE Poultry Live Attenuated Vaccine Product Portfolio
6.8.5 PULIKE Recent Developments/Updates
6.9 PHIBRO ANIMAL HEALTH CORPORATION
6.9.1 PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
6.9.2 PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
6.9.3 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product Portfolio
6.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
6.10 HARBIN PHARMACEUTICAL GROUP
6.10.1 HARBIN PHARMACEUTICAL GROUP Corporation Information
6.10.2 HARBIN PHARMACEUTICAL GROUP Description and Business Overview
6.10.3 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product Portfolio
6.10.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
6.11 MEVAC
6.11.1 MEVAC Corporation Information
6.11.2 MEVAC Poultry Live Attenuated Vaccine Description and Business Overview
6.11.3 MEVAC Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MEVAC Poultry Live Attenuated Vaccine Product Portfolio
6.11.5 MEVAC Recent Developments/Updates
6.12 VENKY’S
6.12.1 VENKY’S Corporation Information
6.12.2 VENKY’S Poultry Live Attenuated Vaccine Description and Business Overview
6.12.3 VENKY’S Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 VENKY’S Poultry Live Attenuated Vaccine Product Portfolio
6.12.5 VENKY’S Recent Developments/Updates
6.13 Dechra
6.13.1 Dechra Corporation Information
6.13.2 Dechra Poultry Live Attenuated Vaccine Description and Business Overview
6.13.3 Dechra Poultry Live Attenuated Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dechra Poultry Live Attenuated Vaccine Product Portfolio
6.13.5 Dechra Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Poultry Live Attenuated Vaccine Industry Chain Analysis
7.2 Poultry Live Attenuated Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Poultry Live Attenuated Vaccine Production Mode & Process
7.4 Poultry Live Attenuated Vaccine Sales and Marketing
7.4.1 Poultry Live Attenuated Vaccine Sales Channels
7.4.2 Poultry Live Attenuated Vaccine Distributors
7.5 Poultry Live Attenuated Vaccine Customers
8 Poultry Live Attenuated Vaccine Market Dynamics
8.1 Poultry Live Attenuated Vaccine Industry Trends
8.2 Poultry Live Attenuated Vaccine Market Drivers
8.3 Poultry Live Attenuated Vaccine Market Challenges
8.4 Poultry Live Attenuated Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Poultry Live Attenuated Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Poultry Live Attenuated Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Poultry Live Attenuated Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Poultry Live Attenuated Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Poultry Live Attenuated Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Poultry Live Attenuated Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Poultry Live Attenuated Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Poultry Live Attenuated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Poultry Live Attenuated Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Poultry Live Attenuated Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Poultry Live Attenuated Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Poultry Live Attenuated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poultry Live Attenuated Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Poultry Live Attenuated Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Poultry Live Attenuated Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Poultry Live Attenuated Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Poultry Live Attenuated Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Poultry Live Attenuated Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Poultry Live Attenuated Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Poultry Live Attenuated Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Poultry Live Attenuated Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Poultry Live Attenuated Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Poultry Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Poultry Live Attenuated Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Poultry Live Attenuated Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Poultry Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Poultry Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Poultry Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Poultry Live Attenuated Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Poultry Live Attenuated Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Poultry Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Poultry Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Poultry Live Attenuated Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Poultry Live Attenuated Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Poultry Live Attenuated Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Poultry Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Poultry Live Attenuated Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Poultry Live Attenuated Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Poultry Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Poultry Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Poultry Live Attenuated Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Poultry Live Attenuated Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Poultry Live Attenuated Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Poultry Live Attenuated Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Poultry Live Attenuated Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Poultry Live Attenuated Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Poultry Live Attenuated Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Poultry Live Attenuated Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Poultry Live Attenuated Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Poultry Live Attenuated Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Poultry Live Attenuated Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Poultry Live Attenuated Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Poultry Live Attenuated Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Poultry Live Attenuated Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. MERCK Corporation Information
Table 71. MERCK Description and Business Overview
Table 72. MERCK Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. MERCK Poultry Live Attenuated Vaccine Product
Table 74. MERCK Recent Developments/Updates
Table 75. Boehringer Ingelheim Corporation Information
Table 76. Boehringer Ingelheim Description and Business Overview
Table 77. Boehringer Ingelheim Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Boehringer Ingelheim Poultry Live Attenuated Vaccine Product
Table 79. Boehringer Ingelheim Recent Developments/Updates
Table 80. CEVA Corporation Information
Table 81. CEVA Description and Business Overview
Table 82. CEVA Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CEVA Poultry Live Attenuated Vaccine Product
Table 84. CEVA Recent Developments/Updates
Table 85. ZOETIS Corporation Information
Table 86. ZOETIS Description and Business Overview
Table 87. ZOETIS Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. ZOETIS Poultry Live Attenuated Vaccine Product
Table 89. ZOETIS Recent Developments/Updates
Table 90. Vaxxinova Corporation Information
Table 91. Vaxxinova Description and Business Overview
Table 92. Vaxxinova Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Vaxxinova Poultry Live Attenuated Vaccine Product
Table 94. Vaxxinova Recent Developments/Updates
Table 95. ELANCO Corporation Information
Table 96. ELANCO Description and Business Overview
Table 97. ELANCO Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. ELANCO Poultry Live Attenuated Vaccine Product
Table 99. ELANCO Recent Developments/Updates
Table 100. QYH BIOTECH Corporation Information
Table 101. QYH BIOTECH Description and Business Overview
Table 102. QYH BIOTECH Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. QYH BIOTECH Poultry Live Attenuated Vaccine Product
Table 104. QYH BIOTECH Recent Developments/Updates
Table 105. PULIKE Corporation Information
Table 106. PULIKE Description and Business Overview
Table 107. PULIKE Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. PULIKE Poultry Live Attenuated Vaccine Product
Table 109. PULIKE Recent Developments/Updates
Table 110. PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
Table 111. PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
Table 112. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. PHIBRO ANIMAL HEALTH CORPORATION Poultry Live Attenuated Vaccine Product
Table 114. PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
Table 115. HARBIN PHARMACEUTICAL GROUP Corporation Information
Table 116. HARBIN PHARMACEUTICAL GROUP Description and Business Overview
Table 117. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. HARBIN PHARMACEUTICAL GROUP Poultry Live Attenuated Vaccine Product
Table 119. HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
Table 120. MEVAC Corporation Information
Table 121. MEVAC Description and Business Overview
Table 122. MEVAC Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. MEVAC Poultry Live Attenuated Vaccine Product
Table 124. MEVAC Recent Developments/Updates
Table 125. VENKY’S Corporation Information
Table 126. VENKY’S Description and Business Overview
Table 127. VENKY’S Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. VENKY’S Poultry Live Attenuated Vaccine Product
Table 129. VENKY’S Recent Developments/Updates
Table 130. Dechra Corporation Information
Table 131. Dechra Description and Business Overview
Table 132. Dechra Poultry Live Attenuated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Dechra Poultry Live Attenuated Vaccine Product
Table 134. Dechra Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Poultry Live Attenuated Vaccine Distributors List
Table 138. Poultry Live Attenuated Vaccine Customers List
Table 139. Poultry Live Attenuated Vaccine Market Trends
Table 140. Poultry Live Attenuated Vaccine Market Drivers
Table 141. Poultry Live Attenuated Vaccine Market Challenges
Table 142. Poultry Live Attenuated Vaccine Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Poultry Live Attenuated Vaccine
Figure 2. Global Poultry Live Attenuated Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Poultry Live Attenuated Vaccine Market Share by Type in 2023 & 2030
Figure 4. NDV Product Picture
Figure 5. Marek ' s Disease Product Picture
Figure 6. IBD Product Picture
Figure 7. Infectious Bronchitis Product Picture
Figure 8. Influenza Product Picture
Figure 9. Other Product Picture
Figure 10. Global Poultry Live Attenuated Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Poultry Live Attenuated Vaccine Market Share by Application in 2023 & 2030
Figure 12. Chicken
Figure 13. Other Poultry
Figure 14. Global Poultry Live Attenuated Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Poultry Live Attenuated Vaccine Market Size (2019-2030) & (US$ Million)
Figure 16. Global Poultry Live Attenuated Vaccine Sales (2019-2030) & (K Units)
Figure 17. Global Poultry Live Attenuated Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 18. Poultry Live Attenuated Vaccine Report Years Considered
Figure 19. Poultry Live Attenuated Vaccine Sales Share by Manufacturers in 2023
Figure 20. Global Poultry Live Attenuated Vaccine Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Poultry Live Attenuated Vaccine Players: Market Share by Revenue in 2023
Figure 22. Poultry Live Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Poultry Live Attenuated Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Poultry Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 25. North America Poultry Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. United States Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Poultry Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 29. Europe Poultry Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 30. Germany Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Poultry Live Attenuated Vaccine Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Poultry Live Attenuated Vaccine Revenue Market Share by Region (2019-2030)
Figure 37. China Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Poultry Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Poultry Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Poultry Live Attenuated Vaccine Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Poultry Live Attenuated Vaccine Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Poultry Live Attenuated Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Poultry Live Attenuated Vaccine by Type (2019-2030)
Figure 56. Global Revenue Market Share of Poultry Live Attenuated Vaccine by Type (2019-2030)
Figure 57. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Poultry Live Attenuated Vaccine by Application (2019-2030)
Figure 59. Global Revenue Market Share of Poultry Live Attenuated Vaccine by Application (2019-2030)
Figure 60. Global Poultry Live Attenuated Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 61. Poultry Live Attenuated Vaccine Value Chain
Figure 62. Poultry Live Attenuated Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
